Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmaceutical approval update.

P & T : a peer-reviewed journal for formulary management·2014
Same author

Pharmaceutical approval update.

P & T : a peer-reviewed journal for formulary management·2014
Same author

Pharmaceutical approval update.

P & T : a peer-reviewed journal for formulary management·2014
Same author

Pharmaceutical approval update.

P & T : a peer-reviewed journal for formulary management·2014
Same author

Pharmaceutical approval update.

P & T : a peer-reviewed journal for formulary management·2014
Same author

Pharmaceutical approval update.

P & T : a peer-reviewed journal for formulary management·2014

Related Experiment Video

Updated: Jun 22, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

Pharmaceutical approval update.

Marvin M Goldenberg

    P & T : a Peer-Reviewed Journal for Formulary Management
    |June 30, 2009
    PubMed
    Summary
    This summary is machine-generated.

    Bendamustine (Treanda) treats chronic lymphocytic leukemia. Hepatitis B immune globulin (HepaGam B) and fibrin sealant (Artiss) are also discussed for preventing hepatitis B infection and in skin graft surgery, respectively.

    Related Experiment Videos

    Last Updated: Jun 22, 2026

    Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
    09:30

    Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

    Published on: March 17, 2023

    Area of Science:

    • Oncology
    • Hepatology
    • Surgery

    Background:

    • Chronic lymphocytic leukemia (CLL) is a common lymphoid malignancy.
    • Hepatitis B infection poses a risk after liver transplantation.
    • Burn injuries often require skin grafting procedures.

    Purpose of the Study:

    • To review the use of bendamustine (Treanda) in treating chronic lymphocytic leukemia.
    • To discuss the role of hepatitis B immune globulin (HepaGam B) in preventing hepatitis B infection post-liver transplant.
    • To evaluate the application of fibrin sealant (Artiss) in skin graft surgery for burn patients.

    Main Methods:

    • Literature review of clinical applications.
    • Analysis of treatment protocols and outcomes.
    • Case study review for specific indications.

    Main Results:

    • Bendamustine demonstrates efficacy in CLL management.
    • HepaGam B is effective in preventing hepatitis B recurrence.
    • Artiss facilitates successful skin graft adherence and healing.

    Conclusions:

    • Bendamustine is a valuable option for CLL.
    • HepaGam B is crucial for hepatitis B prophylaxis in transplant recipients.
    • Artiss enhances outcomes in reconstructive burn surgery.